Medical device maker



revised its 2001 forecast for the second time, raising the low end of its sales and earnings range. The company now expects to see sales of $236 million to $240 million and pro forma earnings per share of $1.25 to $1.34. Last year, Inamed earned $1.56 a share on sales of $240.1 million.

For 2001, Wall Street analysts are expecting earnings of $1.28 per share, according to Thomson Financial/First Call.

For 2002, Inamed now expects per-share earnings in the range of $1.82 to $1.95, compared with the First Call estimate of $1.50. Shares of Inamed closed up 42 cents to $23.54 on the